TNF-related apoptosis-inducing ligand (TRAIL) is a proapoptotic cytokine implicated in cancer cell surveillance. A potential of TRAIL as a cancer-specific therapeutic agent has been proposed, either as a single agent or in combination with chemotherapy. Prolonged exposure of TRAIL-sensitive leukemia cell line, wild-type (WT) HL60 cells to recombinant soluble TRAIL or to cytostatic agents, cytarabine and idarubicin, resulted in the establishment of resistant subclones with distinct phenotypic features. The TRAIL resistant HL60 subclones were characterized by decreased expression of TRAIL and TNFalpha death receptors. These resistant subclones had impaired activation of caspases 8 and 10 in response to TRAIL and TNFalpha, decreased TRAIL-induced nuclear translocation of NFkappaB RelA/p65, and dysregulation of the expression of several apoptosis regulators. Among the TRAIL resistant HL60 subclones we identified two separate phenotypes that differed in the expression of CD14, osteoprotegerin, and several apoptosis regulators. Both these TRAIL resistant HL60 subclones were resistant to TNFalpha, suggesting disruption of the extrinsic apoptotic pathway, but not to cytostatic agents, cytarabine and idarubicin. The concurrently derived HL60 subclones were cytarabine and idarubicin-resistant but remained sensitive to TRAIL-induced apoptosis. We identified distinct pathways for the development of HL60 leukemia cell resistance to apoptosis induction. These findings are relevant for the design of more effective strategies for leukemia therapy.
- MeSH
- akutní promyelocytární leukemie metabolismus patologie MeSH
- apoptóza MeSH
- chemorezistence MeSH
- cytarabin farmakologie MeSH
- financování organizované MeSH
- HL-60 buňky MeSH
- idarubicin farmakologie MeSH
- kaspasy metabolismus účinky léků MeSH
- lidé MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- protein TRAIL farmakologie MeSH
- protein-serin-threoninkinasy metabolismus účinky léků MeSH
- proteiny regulující apoptózu metabolismus účinky léků MeSH
- receptory TNF metabolismus účinky léků MeSH
- rekombinantní proteiny farmakologie MeSH
- TNF-alfa farmakologie MeSH
- TRAIL receptory metabolismus účinky léků MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
BACKGROUND: Sunlight is a very potent environmental factor in skin pathogenesis and can induce skin cancer. UVB irradiation is known to cause oxidative stress, inflammation and especially DNA damage. Topical application of agents with UV absorbing, antioxidant and anti-inflammatory activities is a successful strategy in the protection of the skin against UV-caused damage. OBJECTIVE: To examine the ability of the phenolic fraction of Lonicera caerulea and Vaccinum myrtillus fruits to moderate UVB-induced damage. METHODS: HaCaT keratinocytes, a well-established in vitro system for investigations on UV radiation induced cell damage, were used to assess the effects of pre- and post-treatment with L. caerulea (LCE) and V. myrtillus (VME) phenolic fractions (5-50 mg/l) on keratinocyte damage induced by a solar simulator (295-315 nm). RESULTS: In this study, a model of UVB-induced damage to HaCaT was established. LCE and VME efficiently reduced the extent of DNA breakage (especially at concentrations of 25 and 10 mg/l) together with caspase-3 and -9 activity and DNA laddering induced by UVB (100 or 200 mJ/cm(2)). LCE and VME significantly decreased RONS generation and partially diminished IL-6 expression. LCE pre-treatment also prevented keratinocytes proliferation. CONCLUSION: The results suggest that the phenolic fraction of L. caerulea and V. myrtillus fruits suppress UVB-caused injury to keratinocytes. These results now need to be demonstrated in vivo.
- MeSH
- apoptóza fyziologie účinky léků MeSH
- buněčné linie MeSH
- fenoly farmakologie chemie MeSH
- flavonoidy farmakologie chemie MeSH
- fototoxická dermatitida prevence a kontrola MeSH
- fragmentace DNA účinky léků MeSH
- interleukin-1beta agonisté metabolismus MeSH
- interleukin-6 agonisté metabolismus MeSH
- jednořetězcové zlomy DNA účinky léků MeSH
- kaspasy metabolismus účinky léků MeSH
- keratinocyty účinky léků účinky záření MeSH
- L-laktátdehydrogenasa analýza MeSH
- lidé MeSH
- Lonicera MeSH
- ovoce chemie MeSH
- polyfenoly MeSH
- přípravky chránící proti slunci farmakologie chemie MeSH
- proliferace buněk účinky léků MeSH
- rostlinné extrakty farmakologie MeSH
- ultrafialové záření škodlivé účinky MeSH
- Vaccinium chemie MeSH
- viabilita buněk fyziologie účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
Kaspasy jsou enzymy sehrávající klíčovou roli v programované buněčné smrti – apoptóze. Dysregulace tohoto procesu vede k řadě onemocnění, na jejichž patogenezi se podílí apoptóza. Nemoci lze rozdělit do dvou skupin: na onemocnění s patologickou inhibicí apoptózy (nádorová onemocnění, některé autoimunitní nemoci) a onemocnění s patologickou indukcí apoptózy (neurodegenerativní onemocnění, AIDS). Práce uvádí přehled nejdůležitějších zástupců aktivátorů a inhibitorů kaspas, které apoptózu řídí, a jsou proto v současnosti intenzivně studovány. Spektrofotometricky byl stanoven vliv skupiny derivátů stobadinu, theofylinu a adeninu na aktivitu kaspasy 1. Studované sloučeniny vykázaly inhibiční aktivitu vůči testovanému enzymu, která u jednoho z derivátů překročila 80 %.
Caspases are enzymes which play a key role in programmed cell death – apoptosis. Dysregulation of this process results in a series of disorders in which apoptosis is involved in pathogenesis. Diseases could be divided into two groups – diseases with pathological inhibition of apoptosis (cancer, some autoimmune disorders) and diseases with pathological induction of apoptosis (neurodegenerative disorders, AIDS). The paper lists the most significant activators and inhibitors of caspases as they control apoptosis and hence they are widely studied nowadays. The effects of stobadine, theophylline and adenine derivatives on the activity of caspase 1 was investigated with the use of spectrophotometry. The compounds under study showed an inhibitory effect on the enzyme tested; in one case the inhibitory effect exceeded 80%.
A quaternary benzo[c]phenanthridine alkaloid chelerythrine displays a wide range of biological activities including cytotoxicity to normal and cancer cells. In contrast, less is known about the biological activity of dihydrochelerythrine, a product of chelerythrine reduction. We examined the cytotoxicity of chelerythrine and dihydrochelerythrine in human promyelocytic leukemia HL-60 cells. After 4h of treatment, chelerythrine induced a dose-dependent decrease in the cell viability with IC50 of 2.6 microM as shown by MTT reduction assay. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53%. Decrease in the viability induced by both alkaloids was accompanied by apoptotic events including the dissipation of mitochondrial membrane potential, activation of caspase-9 and -3, and appearance of cells with sub-G1 DNA. Moreover, chelerythrine, but not dihydrochelerythrine, elevated the activity of caspase-8. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry. Besides, both alkaloids were found to induce accumulation of HL-60 cells in G1 phase of the cell cycle. We conclude that both chelerythrine and dihydrochelerythrine affect cell cycle distribution, activate mitochondrial apoptotic pathway, and induce apoptosis and necrosis in HL-60 cells.
- MeSH
- akutní promyelocytární leukemie farmakoterapie patologie MeSH
- alkaloidy aplikace a dávkování farmakologie MeSH
- apoptóza účinky léků MeSH
- benzofenantridiny aplikace a dávkování farmakologie MeSH
- buněčná smrt účinky léků MeSH
- časové faktory MeSH
- DNA nádorová metabolismus účinky léků MeSH
- financování organizované MeSH
- G1 fáze účinky léků MeSH
- HL-60 buňky MeSH
- inhibiční koncentrace 50 MeSH
- kaspasy metabolismus účinky léků MeSH
- lidé MeSH
- membránový potenciál mitochondrií účinky léků MeSH
- protinádorové látky aplikace a dávkování farmakologie MeSH
- viabilita buněk účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- srovnávací studie MeSH
The interaction between retinoids and transforming growth factor-beta1 (TGF-beta1) leading to regulation of proliferation, differentiation and apoptosis is not still fully understood. In this study, we demonstrated that a combination treatment with all-trans retinoic acid (ATRA) and TGF-beta1 led to the enhancement of ATRA-induced suppression of cell proliferation, which is accompanied by inhibition of ATRA-induced apoptosis in human leukemia HL-60 cells. This effect was preceded by the arrest of cells in G0/G1 cell cycle phase linked with pRb protein dephosphorylation, continuous accumulation of p21 and transiently increased level of p27, inhibitors of cyclin-dependent kinases. Inhibition of ATRA-induced apoptosis by TGF-beta1 was associated with an increased level of Mcl-1 protein, an anti-apoptotic member of Bcl-2 family, but not with inhibition of mitochondrial membrane depolarization. Levels of other Bcl-2 family proteins (Bcl-2, Bcl-X(L), Bad, Bak, Bax) were unaffected by simultaneous ATRA and TGF-beta1 treatment, when compared to ATRA alone. Upregulation of c-FLIP(L) protein, an inhibitor of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), correspond with inhibition of ATRA-induced (autocrine TRAIL-mediated) caspase-8 activation and apoptosis. These results suggest that apoptosis inhibition associated with proliferation block could depend on modulation of the TRAIL apoptotic pathway and regulation of the Mcl-1 protein level. In summary, we demonstrate that the balance of processes leading to regulation of proliferation and differentiation of myeloid cells can modulate cell sensitivity to apoptosis-inducing stimuli.
- MeSH
- aktivace enzymů účinky záření MeSH
- antigeny CD11b fyziologie účinky léků MeSH
- buněčná diferenciace účinky léků MeSH
- buněčný cyklus účinky léků MeSH
- FLIP (buněčný) MeSH
- fosforylace MeSH
- G0 fáze účinky léků MeSH
- G1 fáze účinky léků MeSH
- granulocyty fyziologie účinky léků MeSH
- HL-60 buňky MeSH
- inhibitor p21 cyklin-dependentní kinasy biosyntéza účinky léků MeSH
- intracelulární signální peptidy a proteiny farmakologie metabolismus MeSH
- kaspasa 3 MeSH
- kaspasa 8 MeSH
- kaspasy metabolismus účinky léků MeSH
- lidé MeSH
- membránové glykoproteiny farmakologie metabolismus MeSH
- mitochondriální membrány fyziologie účinky léků MeSH
- nádorové buňky kultivované MeSH
- nádorové proteiny metabolismus účinky léků MeSH
- proliferace buněk účinky léků MeSH
- protein TRAIL MeSH
- protein X asociovaný s bcl-2 metabolismus účinky léků MeSH
- proteiny regulující apoptózu farmakologie metabolismus MeSH
- protoonkogenní proteiny c-bcl-2 metabolismus účinky léků MeSH
- reaktivní formy kyslíku metabolismus MeSH
- retinoblastomový protein metabolismus účinky léků MeSH
- synergismus léků MeSH
- TNF-alfa farmakologie metabolismus MeSH
- transformující růstový faktor beta farmakologie MeSH
- transformující růstový faktor beta1 MeSH
- tretinoin antagonisté a inhibitory farmakologie MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
BACKGROUND: Dysregulation of the balance between cell growth and death in the colonic epithelium is associated with cancer promotion. Understanding how cell death in this self-renewing tissue is regulated and how it is influenced by interaction of specific dietary components, especially fat and fibre, could lead to improved treatment and prevention strategies for cancer. AIM OF THE STUDY: The effects of two types of polyunsaturated fatty acids (PUFAs)--arachidonic (AA, 20:4, n-6) or docosahexaenoic (DHA, 22:6, n-3)--on the response of human colon adenocarcinoma HT-29 cells to sodium butyrate (NaBt) were investigated. METHODS: The parameters reflecting cell proliferation and cell death were studied together with oxidative response, mitochondrial membrane potential (MMP) and changes of selected regulatory molecules associated with cell cycle (p27(Kip1) and p21(Cip1/WAF1)) and apoptosis (caspase-3, caspase-9, poly (ADP-ribose) polymerase--PARP, Bcl-2, Bax, Bak,Mcl-1). RESULTS: We demonstrated that pre-treatment with either AA or DHA attenuated cell cycle arrest caused by NaBt which is associated with modulation of p27(Kip1), but not p21(Cip1/WAF1) protein expression. On the other hand, PUFAs sensitised HT-29 cells to NaBt-induced apoptosis. An increased amount of floating cells and cells in the subG(0)/G(1) population was associated with increased reactive oxygen species production, lipid peroxidation, decrease of MMP, activation of caspase-3 and -9, PARP cleavage, and decrease in the expression of antiapoptotic Mcl-1 protein. The observed effects were modulated by the addition of a protein synthesis inhibitor, cycloheximide, and partially reversed by the antioxidant Trolox. CONCLUSIONS: PUFAs may have beneficial effects in the colon enhancing apoptosis induced by NaBt. Alteration of cell membrane lipid composition and potentiation of oxidative processes accompanied by changes in mitochondria followed by stimulation of apoptotic cascade components play a role in these effects.
- MeSH
- adenokarcinom * metabolismus MeSH
- apoptóza účinky léků MeSH
- buněčný cyklus účinky léků MeSH
- buňky HT-29 MeSH
- butyráty * metabolismus MeSH
- fluorescenční mikroskopie MeSH
- kaspasa 3 MeSH
- kaspasa 9 MeSH
- kaspasy metabolismus účinky léků MeSH
- kyseliny arachidonové aplikace a dávkování MeSH
- kyseliny dokosahexaenové aplikace a dávkování MeSH
- lidé MeSH
- membránové potenciály účinky léků MeSH
- nádory tračníku * metabolismus MeSH
- nenasycené mastné kyseliny * metabolismus MeSH
- peroxidace lipidů účinky léků MeSH
- poly(ADP-ribosa)polymerasy metabolismus účinky léků MeSH
- protoonkogenní proteiny metabolismus účinky léků MeSH
- průtoková cytometrie MeSH
- reaktivní formy kyslíku metabolismus MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- western blotting MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- MeSH
- apoptóza účinky záření MeSH
- degenerace retiny MeSH
- fotoreceptory účinky léků MeSH
- inhibitory kaspas MeSH
- kalpain účinky léků MeSH
- kaspasy účinky léků MeSH
- kultivované buňky účinky léků MeSH
- oxid dusnatý metabolismus MeSH
- oxidační stres MeSH
- scavengery volných radikálů farmakologie MeSH
- techniky in vitro MeSH
- vitamin E analogy a deriváty MeSH
- MeSH
- apoptóza * účinky léků MeSH
- chelátová terapie MeSH
- deferipron aplikace a dávkování farmakologie MeSH
- deferoxamin aplikace a dávkování farmakologie MeSH
- dospělí MeSH
- hemoxygenasa-1 analýza účinky léků MeSH
- imunohistochemie metody MeSH
- kaspasy analýza účinky léků MeSH
- lidé MeSH
- talasemie * farmakoterapie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- MeSH
- buněčné jadérko fyziologie patologie účinky léků MeSH
- doxorubicin toxicita MeSH
- genetické techniky MeSH
- kaspasy analýza účinky léků MeSH
- krysa rodu rattus MeSH
- myokard enzymologie MeSH
- nežádoucí účinky léčiv etiologie MeSH
- srdce genetika účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
- MeSH
- buněčná smrt MeSH
- buněčné jadérko fyziologie účinky léků MeSH
- cisplatina toxicita MeSH
- HeLa buňky enzymologie genetika účinky léků MeSH
- jaderné proteiny metabolismus MeSH
- kaspasy fyziologie účinky léků MeSH
- lidé MeSH
- RNA jaderná fyziologie účinky léků MeSH
- techniky in vitro MeSH
- Check Tag
- lidé MeSH